Home › Funds › Third Point › RLAY
Third Point position in RLAY
RELAY THERAPEUTICS INC · Health Care
Latest position (Q3 2022)100.00K sh
Reported value held$2.24M
Portfolio Weight0.04%
First reportedQ3 2022
Last changeNew
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2022 | 100.00K | $2.24M | New |
Other funds holding RLAY
- Fidelity Management & Research (FMR) 20.11M sh · $376.26M · Q2 2026
- Casdin Capital 16.04M sh · $300.02M · Q2 2026
- BlackRock Inc 15.29M sh · $286.04M · Q2 2026
- Geode Capital Management 4.73M sh · $88.45M · Q2 2026
- Vanguard Group 9.69M sh · $81.99M · Q4 2025
- Morgan Stanley 3.85M sh · $72.05M · Q2 2026
- Goldman Sachs Group 3.41M sh · $63.78M · Q2 2026
- Bank of America Corp 2.70M sh · $50.43M · Q2 2026
- Arrowstreet Capital 2.24M sh · $41.89M · Q2 2026
- Northern Trust Corp 1.95M sh · $36.55M · Q2 2026
- Franklin Resources 1.86M sh · $34.74M · Q2 2026
- Charles Schwab Investment Management 1.50M sh · $28.08M · Q2 2026